
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical gel containing sodium hyaluronate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing hyaluronic acid (sodium hyaluronate) is listed. Products containing it are filed in the directory as over-the-counter monograph drugs and unapproved drugs, in gel, cream, liquid, cloth and solution forms.
Gel bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Hyaluronic acid is a natural water-binding sugar polymer that compounding pharmacies include in topical creams, gels, serums and combination preparations by prescription.
Hyaluronic acid (hyaluronan, often used as its sodium salt) is a long chain of repeating sugar units found throughout the body, about half of it in the skin. It binds and holds large amounts of water, which keeps skin hydrated and joint fluid slippery, and it signals to cells during wound repair. No hyaluronic acid product is FDA-approved as a drug. Manufactured forms are regulated as medical devices: injectable dermal fillers (Juvederm and others) approved for specific facial and hand areas, intra-articular products (Euflexxa and others) for pain of knee osteoarthritis, and Bionect cream and gel, cleared as a wound dressing. Over-the-counter serums are cosmetics. A prescriber might order compounded hyaluronic acid in a topical vehicle alongside a corticosteroid, retinoid or anti-inflammatory, or in a base without a particular preservative. Compounded preparations are not FDA-approved and require a prescription.
Topical hyaluronic acid has no boxed warning and is a normal component of skin, so reactions are uncommon. The Bionect dressing label warns that prolonged use can cause sensitization and that the product should not meet quaternary ammonium disinfectants, which make hyaluronic acid precipitate; stop and call your prescriber for rash, hives, itching, swelling or trouble breathing. The serious risks FDA describes, such as blood vessel blockage, tissue death, blindness, infection and hard nodules, belong to injectable fillers given by a licensed provider, not to topical use; FDA says never to inject yourself or buy filler online. Tell your prescriber if you are allergic to bacteria-derived hyaluronic acid or have a skin infection in the area. No drug interactions are listed for topical use. Bionect states no information is available on pregnancy or nursing, and no LactMed record exists. If side effects bother you, talk to your prescriber or pharmacist.
Hyaluronic acid is a non-sulfated glycosaminoglycan of repeating D-glucuronic acid and N-acetylglucosamine, ranging from a few thousand to twenty million daltons. High molecular weight chains predominate in intact tissue and provide viscoelasticity and water retention; low molecular weight fragments act as inflammatory and angiogenic signals through CD44, RHAMM and ICAM-1. Turnover is rapid: minutes in blood and under a day in skin. Synthesis rises during wound healing, where it scaffolds fibroblast migration and angiogenesis. No FDA-approved drug exists; device clearances cover dermal fillers (specified facial and hand sites), intra-articular viscosupplements for knee osteoarthritis, and Bionect 0.2% cream and gel as a dressing for dermal ulcers, abrasions, donor sites, incisions and first- and second-degree burns. Concentration, molecular weight grade and vehicle are per prescriber; the Bionect label's incompatibility with quaternary ammonium compounds matters for preservative selection. Monitoring is clinical: local sensitization with prolonged use and wound progress. Not a controlled substance.
Wash your hands. Apply the amount on your label to clean, dry skin and spread it in a thin layer. For a metered pump, your label states the number of presses. For a dosing syringe, push the plunger to the mark. Let the gel dry before covering with clothing. Wash your hands afterward and keep the site from touching other people until it has dried. Do not apply to broken skin unless told to.
A gel can have a nonaqueous or a water-based base, and USP <795> sets its default beyond-use date by water content, not by the word gel. A nonaqueous gel usually carries a beyond-use date of up to 180 days at room temperature or refrigerated. A water-based gel carries up to 35 days with a preservative, or 14 days refrigerated without one. Your label states which applies. Keep the container closed, away from heat and open flame if it contains alcohol, out of reach of children, and discard after the beyond-use date on your label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)